Aier Eye Hospital Group (China)

Running trials

• Recruiting

  Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

  NCT07317934· Phase 3· Source

• Recruiting

  Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

  NCT07515079· Phase 3· Source

• Active, not recruiting

  TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

  NCT05461339· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic eye disease1 recruiting
• Macular degeneration1 recruiting

Researchers

No researcher is linked here yet.

Trial sites

• Aier Eye Hospital(Changsha)1 trial
• Aier Eye Hospital Group Co., LTD. Changsha Aier Eye Hospital1 trial
• Changsha Aier Eye Hospital1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Glaucoma39 works · 0 trials
• Diabetic eye disease20 works · 1 trial
• Macular degeneration19 works · 2 trials
• Retinitis pigmentosa7 works · 0 trials